Back
SpringWorks Therapeutics Stock Price Chart

Meet the Founder that's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
SWTX
SpringWorks Therapeutics
Last Price:
$50.27
Seasonality Move:
8.06%
7 Day Trial
ALL ACCESS PASS
$
7

Apple just traded your privacy for $20 Billion
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bearish and SWTX is experiencing slight buying pressure.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.41 | Buy |
20-day SMA: | 52.63 | Sell |
50-day SMA: | 45.79 | Buy |
200-day SMA: | 38.85 | Buy |
8-day EMA: | 50.65 | Buy |
20-day EMA: | 50.74 | Buy |
50-day EMA: | 47.27 | Buy |
200-day EMA: | 40.73 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.75 | Buy |
Relative Strength Index (14 RSI): | 52.26 | Buy |
Chaikin Money Flow: | 672193 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.18 - 56.96) | Sell |
Bollinger Bands (100): | (32.59 - 49.25) | Buy |
SpringWorks Therapeutics Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 51.08 while SWTX 8-day simple moving average is 50.41, which is a Buy signal.
-
The stock price of SWTX is 51.08 while SpringWorks Therapeutics 20-day SMA is 52.63, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 45.79 while SWTX share price is 51.08, making it a Buy technically.
-
SWTX stock price is 51.08 and SpringWorks Therapeutics 200-day simple moving average is 38.85, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
46
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $51.08. The Score for SWTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.8B
Price in USD:
51.08
Share Volume:
1.5M
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
46
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 51.08 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 51.08 while SWTX 8-day exponential moving average is 50.65, which is a Buy signal.
-
The stock price of SWTX is 51.08 while SpringWorks Therapeutics 20-day EMA is 50.74, which makes it a Buy.
-
SpringWorks Therapeutics 50-day exponential moving average is 47.27 while SWTX share price is 51.08, making it a Buy technically.
-
SWTX stock price is 51.08 and SpringWorks Therapeutics 200-day simple moving average is 40.73, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is 0.75, suggesting SpringWorks Therapeutics is a Buy
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 52.26, which suggest SpringWorks Therapeutics is overbought
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (50.18 - 56.96), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (32.59 - 49.25), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.